You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. ANTIVIRAL SCREENING ASSAYS BASED ON HCV REPLICONS

    SBC: APATH, LLC            Topic: N/A

    DESCRIPTION (Provided by applicant): Hepatitis C virus (HCV) is the most prevalent chronic blood-borne infection in the U.S and a global health problem. Approximately 4 million individuals in the U.S. and 170 million individuals worldwide are chronically infected. As much as 40 percent of chronic liver disease is HCV related and this results in up to 10,000 deaths each year. Despite improvements, ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  2. Fretting Fatigue Model

    SBC: APES INC.            Topic: N/A

    "Fretting is a wear phenomenon that occurs between two mating surfaces: it is adhesive in nature, and vibration is its essential causative factor. Usually fretting is accompanied by corrosion. In general, fretting occurs between two tight fitting surfacesthat are subjected to a cyclic, relative motion of extremely small amplitude. Fretted regions are highly sensitive to fatigue cracking. Under fre ...

    SBIR Phase II 2002 Department of DefenseAir Force
  3. TARGET VALIDATION METHODS FOR NEMATODE CONTROL AGENTS

    SBC: Divergence, Inc.            Topic: N/A

    Infections by roundworm parasites, called nematodes, result in human mortality and morbidity, especially in subtropical and tropical regions of Africa, Asia, and the Americas. The World Health Organization estimates 2.9 billion people are infected. There are 595 known nematode parasites of vertebrates including hundreds that infect domesticated animals. Widespread use of drugs to control parasites ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  4. COLD-SENSITIVE MUTANTS OF TAQ DNA POLYMERASE

    SBC: DNA POLYMERASE TECHNOLOGY, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): A hot start is beneficial or necessary for efficiency and reliability of a large portion of PCR reactions. The most demanding PCR reactions are especially dependent on a hot start. A heat switch can be added to PCR protocols by any of several manual or built-in methods, all of which have drawbacks, such as narrow conditions, extra expense, extra steps, prone to ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  5. Development and Application of the High Bandwidth Powered Resonance Tube

    SBC: INNOVATIVE TECH APPLICATIONS LLC            Topic: N/A

    "The proposed Phase 2 program focuses on the development of Powered Resonance Tube (PRT) actuators for application to Active Flow Control (AFC). For effective control across the full operating envelope of an air vehicle, high bandwidth and authority arerequired. In Phase 1, a new variable-frequency PRT actuator concept was developed and its feasibility was demonstrated. In Phase 2, the new actu ...

    STTR Phase II 2002 Department of DefenseAir Force
  6. NEOCARTILAGE CHONDRAL ALLOGRAFT DEVELOPMENT

    SBC: ISTO TECHNOLOGIES            Topic: N/A

    Because chondrocytes in culture are phenotypically unstable, techniques to grow tissue-engineered cartilage for the repair of injured or arthritic joints have met with limited success. Using human donor chondroctyes, we have developed an innovative method for producing what we call neocartilage, a viable, biomechanically stable tissue that we plan to commercialize for the repair of chondral defect ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  7. SOLID SITOSTANOL FORMULATIONS LOWER LDL-CHOLESTEROL

    SBC: LIFELINE TECHNOLOGIES, INC.            Topic: N/A

    Incorporation of a new water-based sterol/stanol formulation system in foods and capsules lowers intestinal cholesterol absorption. This methodology is fat-free and provides a distinct improvement over existing inflexible oil-based strategies that increase the consumer's caloric load. A series of 14-week, double blind placebo controlled trials will examine the effect of fo ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  8. Affordable High Performance Shock and Vibration Mitigating Mount

    SBC: PRODUCTION PRODUCTS MANUFACTURING & SALES CO., INC.            Topic: N/A

    "In Phase I Production Products designed a polyurethane shock andvibration mount system, fabricated prototypes, performed loadstroke and shock testing, analytically predicted shock andvibration performance, and demonstrated the ability to meetanalytical predictions. Shock mount designs were subjected toshock tests to over 200 g's with an overall reduction in maximumacceleration of a factor of over ...

    SBIR Phase II 2002 Department of DefenseNavy
  9. ADENOVIRUS REPLICATION-COMPETENT ANTI-CANCER VECTOR

    SBC: VIRRX, INC            Topic: N/A

    DESCRIPTION (provided by applicant): We have developed several tumor-specific and tissue-specific replication-competent adenoviruses (Ad) vectors for cancer gene therapy. One vector, named KD3, has a mutation in the E1A gene such that KD3 cannot replicate in, and destroy, "normal" cells. However, KD3 can replicate in cancer cells because they have a microenvironment conducive to KD3 replication. ...

    STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government